Gray Matter Volume Loss in Proposed <scp>Brain‐First</scp> and <scp>Body‐First</scp> Parkinson's Disease Subtypes-Reference-Cited by-同舟云学术

Gray Matter Volume Loss in Proposed Brain‐First and Body‐First Parkinson's Disease Subtypes

Author:

Banwinkler Magdalena¹^ORCID,Dzialas Verena¹²^ORCID,Hoenig Merle C.¹³^ORCID,van Eimeren Thilo¹⁴^ORCID,

Affiliation:

1. Faculty of Medicine and University Hospital Cologne, Department of Nuclear Medicine University of Cologne Cologne Germany

2. Faculty of Mathematics and Natural Sciences University of Cologne Cologne Germany

3. Institute for Neuroscience and Medicine II, Molecular Organization of the Brain Research Center Juelich Juelich Germany

4. Faculty of Medicine and University Hospital Cologne, Department of Neurology University of Cologne Cologne Germany

Funder

Verily Life Sciences

Takeda Pharmaceutical Company

Sanofi Genzyme

Genentech

Roche

Pfizer

Meso Scale Diagnostics

Merck

Eli Lilly and Company

Celgene

Biogen

AbbVie

Michael J. Fox Foundation for Parkinson's Research

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

Reference62 articles.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献